Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00307_DB00759> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00307_DB00759 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00307_DB00759 label "DDI between Bexarotene and Tetracycline - Tetracycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. Due to the risk of developing pseudotumor cerebri (also known as intracranial hypertension), avoid this combination of drugs if possible. If used concomitantly, monitor for evidence of this interaction (eg, dizziness, diplopia, headache). [drugbank_resource:DB00307_DB00759]" assertion.
- drugbank_resource:DB00307_DB00759 identifier "drugbank_resource:DB00307_DB00759" assertion.
- drugbank_resource:DB00307_DB00759 title "DDI between Bexarotene and Tetracycline - Tetracycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. Due to the risk of developing pseudotumor cerebri (also known as intracranial hypertension), avoid this combination of drugs if possible. If used concomitantly, monitor for evidence of this interaction (eg, dizziness, diplopia, headache)." assertion.